Antimicrobial Prophylaxis to Prevent Opportunistic Infections in Patients with Chronic Lymphocytic Leukemia after Allogeneic Blood or Marrow Transplantation

References

• Rabinowe S. N., Soiffer R. J., Gribben J. G., et al. Autologous and allogeneic bone marrow transplantation for poor prognosis patients with B-cell chronic lymphocytic leukemia. Blood 1993; 82: 1366–1376
   PubMed Web of Science ®Google Scholar
• Khouri I. F., Keating M. J., Vriesendorp H. M., et al. Autologous and allogenic bone marrow transplantation for chronic lymphocytic leukemia: preliminary results. J. Clin. Oncol 1994; 12: 748–758
   PubMed Web of Science ®Google Scholar
• Mehta J., Powles R., Singhal S., et al. Allogeneic bone marrow transplantation for chronic lymphocytic leukemia. Blood 1995; 86(Suppl 1)958a
   PubMedGoogle Scholar
• Martino R., Brunet S., Garcfa A., et al. Various patterns of chimerism after allogeneic bone marrow transplantation for advanced chronic lymphocytic leukemia. Bone Marrow Transplant 1995; 16: 783–-787
   PubMed Web of Science ®Google Scholar
• Michallet M., Archimbaud E., Bandini G., et al. HLA-identical sibling bone marrow transplantation in younger patients with chronic lymphocytic leukemia. European Group for Blood and Marrow Transplantation and the International Bone Marrow Transplant Registry. Ann. Intern. Med 1996; 124: 311–315
   PubMed Web of Science ®Google Scholar
• Zomas A., Mehta J., Powles R., et al. Unusual infections following allogeneic bone marrow transplantation for chronic lymphocytic leukemia. Bone Marrow Transplant 1994; 14: 799–803
   PubMed Web of Science ®Google Scholar
• Bartlett-Pandite L., Soiffer R., Gribben J. G., et al. Autologous and allogeneic bone marrow transplantation for B-cell CLL: balance between toxicity and efficacy. Blood 1994; 84(Suppl 1)536a
   Google Scholar
• Chang J., Powles R., Mehta J., Paton N., Treleaven J., Jameson B. Listeriosis in bone marrow transplant recipients: incidence, clinical features, and treatment. Clin. Infect. Dis 1995; 21: 1289–1290
   PubMed Web of Science ®Google Scholar
• Mehta J., Powles R., Singhal S., Iveson T., Treleaven J., Catovsky D. Clinical and hematologic response of chronic lymphocytic and prolymphocytic leukemia persisting after allogeneic bone marrow transplantation with the onset of acute graft-versus-host disease: possible role of graft-versus-leukemia. Bone Marrow Transplant 1996; 17: 371–375
   PubMed Web of Science ®Google Scholar
• Dillman R. O., Mick R., McIntyre O. R. Pentostatin in chronic lymphocytic leukemia: a phase II trial of Cancer and Leukemia group B, J. Clin. Oncol 1989; 7: 433–-438
   Web of Science ®Google Scholar
• Louthrenoo W., Schumacher H. R. Listeria monocytogenes osteomyelitis complicating leukemia: report and literature review of Listeria osteoarticular infections. J. Rheumatol 1990; 17: 107–110
   PubMed Web of Science ®Google Scholar
• Puccio C. A., Mittelman A., Lichtman S. M., et al. A loading dose/continuous infusion schedule of fludarabine phosphate in chronic lymphocytic leukemia. J. Clin. Oncol 1991; 9: 1562–1569
   PubMed Web of Science ®Google Scholar
• Hiddemann W., Rottmann R., Wormann B., et al. Treatment of advanced chronic lymphocytic leukemia by fludarabine. Results of a clinical phase-II study. Ann. Hematol 1991; 63: 1–4
   PubMed Web of Science ®Google Scholar
• Anaissie E., Kontoyiannis D. P., Kantarjian H., Elting L., Robertson L. E., Keating M. Listeriosis in patients with chronic lymphocytic leukemia who were treated with fludarabine and prednisone. Ann. Intern. Med 1992; 117: 466–469
   PubMed Web of Science ®Google Scholar
• Singhal S., Powles R., Treleaven J., Long S., Rowland A., Mehta J. Comparison of cell yields in a double-blind randomized study of allogeneic marrow versus blood stem cell transplantation. Br. J. Haematol 1996; 93(Suppl 1)37
   Google Scholar
• Mehta J., Powles R., Singhal S., et al. Transfusion requirements after bone marrow transplantation from HLA-identical siblings: effects of donor-recipient ABO incompatibility. Bone Marrow Transplant 1996; 18: 151–156
   PubMed Web of Science ®Google Scholar
• Mehta J., Powles R., Singhal S., et al. T-cell depleted allogeneic bone marrow transplantation from a partially HLA-mismatched unrelated donor for progressive chronic lymphocytic leukemia and fludarabine-induced bone marrow failure. Bone Marrow Transplant 1996; 17: 881–883
   PubMed Web of Science ®Google Scholar
• Masur H. Prevention and treatment of pneumocystis pneumonia. N. Engl. J. Med 1992; 327: 1853–1860
   PubMed Web of Science ®Google Scholar
• Kasper L. H. Toxoplasma infections and toxoplasmosis. Harrison's Principles of Internal Medicine, 13th ed., K. J. Isselbacher, E. Braunwald, J. D. Wilson, J. B. Martin, A. S. Fauci, D. L. Kasper. McGraw-Hill, New York. 1994; 903–910
   Google Scholar
• Foot A. B., Garin Y. J., Ribaud P., Devergie A., Derouin F., Gluckman E. Prophylaxis of toxoplasmosis infection with pyrimethamine/sulfadoxine (Fansidar) in bone marrow transplant recipients. Bone Marrow Transplant 1994; 14: 241–245
   PubMed Web of Science ®Google Scholar
• Slavin M. A., Osborne B., Adams R., et al. Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation-a prospective, randomized, double-blind study. J. Infect. Dis 1995; 171: 1545–1552
   PubMed Web of Science ®Google Scholar
• Rege K., Mehta J., Treleaven J., et al. Fatal pneumococcal infections following allogeneic bone marrow transplantation. Bone Marrow Transplant 1994; 14: 903–906
   PubMed Web of Science ®Google Scholar
• Schuchat A., Broome C. V. Infections caused by Listeria monocytogenes. Harrison's Principles of Internal Medicine, 13th ed, K. J. Isselbacher, E. Braunwald, J. D. Wilson, J. B. Martin, A. S. Fauci, D. L. Kasper. McGraw-Hill, New York 1994; 631–632
   Google Scholar
• Li C. R., Greenberg P. D., Gilbert M. J., Goodrich J. M., Riddell S. R. Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxis. Blood 1994; 83: 1971–1979
   PubMed Web of Science ®Google Scholar
• Singhal S., Mehta J., Powles R., et al. Three weeks of ganciclovir for cytomegaloviraemia after allogeneic bone marrow transplantation. Bone Marrow Transplant 1995; 15: 777–781
   PubMed Web of Science ®Google Scholar
• Chang J., Powles R., Singhal S., Jameson B., Treleaven J., Mehta J. Foscarnet for cytomegalovirus infection after allogeneic bone marrow transplantation. Clin. Infect. Dis 1996; 22: 583–584
   PubMed Web of Science ®Google Scholar
• Walter E. A., Greenberg P. D., Gilbert M. J., et al. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N. Engl. J. Med 1995; 333: 1038–1044
   PubMed Web of Science ®Google Scholar
• Mehta B. C. Geographical variations in blood dis-ease: India. Oxford Textbook of Medicine, 2nd ed., D. J. Weatherall, J. G. G. Ledingham, D. A. Warrell. Oxford Scientific Publications, Oxford 1987; 19.270–19.273.
   Google Scholar